Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy

Auris Nasus Larynx

Volumn 35, Issue 2, 2008, Pages 213-219

  Ahmed, Wael A ^a   Suzuki, Kenji ^a   Imaeda, Yoshihiro ^a   Horibe, Yoshimune ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b Daidou Hospital   (Japan)

Author keywords

Anterior commissure; Glottic cancer; Ki 67; p53 and EGFR; Radiotherapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ANTERIOR COMMISSURE; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; EARLY CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNGEAL BIOPSY; LARYNX CANCER; LINEAR ACCELERATOR; MALE; PROGNOSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GLOTTIS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIATION TOLERANCE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 41549134651     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2007.08.011     Document Type: Article

References (39)

1. Le Q.T., Fu K.K., Kroll S., Ryu J.K., Quivey J.M., Meyler T.S., et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int Radiat Oncol Biol Phys 39 (1997) 115-126
2. Maheshwar A.A., and Gaffney C.C. Radiotherapy for T1 glottic carcinoma: impact of anterior commissure involvement. J Laryngol Otol 115 (2001) 298-301
3. Nozaki M., Furuta M., Murakami Y., Izawa Y., Iwasaki N., Takahashi H., et al. Radiation therapy for T1 glottic cancer: involvement of the anterior commissure. Anti cancer Res 20 (2000) 1121-1124
4. Rucci L., Gammarota L., and Gallo O. Carcinoma of the anterior commissure of the larynx: II. proposal of a new staging system. Ann Otol Rhinol Laryngol 105 (1996) 391-396
5. Barbosa M.M., Araujo Jr. V.J., Boasquevisque E., Carvalho R., Romano S., Lima R.A., et al. Anterior vocal commissure invasion in laryngeal carcinoma diagnosis. Laryngoscope 115 (2005) 724-730
6. Gerdes J., Lemke H., Baisch H., Wacker H.H., Schwab U., and Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by mononuclear antibody Ki-67. J Immunol 133 (1984) 1710-1715
7. Brown D.C., and Gatter K.C. Monoclonal antibody KI-67: its use in histopathology. Histopathology 17 (1990) 489-503
8. Wilson G.D., Saunders M.I., Dische S., Daley F.M., Robinson B.M., Martindale C.A., et al. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumors. Cell Prolif 29 (1996) 141-152
9. Key G., Becker M.H.G., Baron B., Duchrow M., Schluter C., Flad H.D., et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68 (1993) 629-636
10. Raybaud-Diogene H., Fortin A., Morency R., Roy J., Monteil R.A., and Tetu B. Markers of radioresistance in squamous cell carcinoma of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol 15 (1997) 1030-1038
11. Ronald N.J., Caslin A.W., Bowie G.L., and Jones A.S. Has the cellular proliferation marker Ki-67 any clinical relevance in squamous cell carcinoma of the head and neck?. Clin Otolaryngol Allied Sci 19 (1994) 13-18
12. Lera J., Lara P.C., Perez S., Cabrera J.L., and Santana C. Tumor proliferation, p53 expression and apoptosis in laryngeal cancer: relation to the results of radiotherapy. Cancer 83 (1998) 2493-2501
13. Welkoborsky H.J., Hinni M., Dienes H.P., and Mann W.J. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 104 (1995) 503-510
14. Kropveld A., Slootweg P.J., Blankenstein M.A., Terhaad C.H., and Hordijk G.J. Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope 108 (1998) 1548-1552
15. Krecicki T., Jelen M., Zalesska-Krecicka M., and Szkudlarek T. Ki-67 immunostaining and prognosis in laryngeal cancer. Clin Otolaryngol Allied Sci 23 (1998) 539-542
16. Ryan A.J., Danish R., Gottlieb C.A., and Clarke M.F. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol 13 (1993) 711-719
17. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
18. Gomez-lazaro M., Fernandez-Gomez F.J., and Jordan J. p53: twenty five years understanding the mechanism of genome protection. J Physiol Biochem 60 4 (2004) 287-307
19. Brachman D.G., Beckett M., Graves D., Haraf D., Vokes E., and wischelbaum R.R. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53 (1993) 3667-3669
20. Siles E., Villalobos M., Valenzuela M.T., Nunez M.I., Gordon A., McMillan T.J., et al. Relationship between p53 status and radiosensitivity in human tumor cell lines. Br J Cancer 73 (1996) 581-588
21. Schnu{combining double acute accent}rch H.G., Stegmu{combining double acute accent}ller M., Vering A., Bechmann M.W., and Bender H.G. Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor. Eur J Cancer 30A 4 (1994) 491-496
22. Chakrabarty S., Rajagopal S., and Huang S. Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells. Clin Exp Metastasis 13 3 (1995) 191-195
23. Maurizi M., Almadori G., Ferrandina G., Distefano M., Romanini M.E., Cadoni G., et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74 (1996) 1253-1257
24. Stanton P., Richards S., Reeves J., Nikolic M., Edington K., Clark L., et al. Epidermal growth factor receptor expression by human squamous cell carcinoma of the head and neck, cell lines and xenografts. Br J Cancer 70 (1994) 427-433
25. Krecicki T., Jelen M., Zalesska-Krecicka M., Rak J., Szkudlarek T., and Jelen-Krazeszewska J. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol 35 (1999) 180-186
26. Rubin Grandis J., Melhem M.F., Gooding W.E., Day R., Holst V.A., Wagener M.M., et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90 (1998) 824-832
27. Twentyman R.R. Radiation response of tumors: experimental. In: Bleehen N.M. (Ed). Radiobiology in radiotherapy (1988), Springer, Heidelberg Berlin New York 9-15
28. Condon L.T., Ashman J.N., Ell S.R., Stafford N.D., Greenman J., and Cawkwell L. Overexpression of BCL-2 in squamous cell carcinoma of the larynx: a marker of radioresistance. Int J Cancer 100 (2002) 472-475
29. Bjork-Eriksson T., West C.M., Chetskovska E., Svensson M., Karlsson E., Magnussson B., et al. The lack of correlation between proliferation (Ki-67, PCNA, LI, TPOT), p53 expression and radiosensitivity for head and neck cancers. Br J Cancer 80 (1999) 1400-1404
30. Narayana A., Vaughan A.T.M., Gunaratne S., Kathuria S., Walter S.A., and Reddy S.P. Is p53 an independent prognostic factor in patients with laryngeal carcinoma?. Cancer 82 (1998) 286-291
31. Kastan M.B., OnyekwereO, Sidransky D., Voglestein B., and Craig R.W. Participation of p53 protein in cellular response to DNA damage. Cancer 51 (1991) 6304-6311
32. Awwad S., Jaros E., Somes J., and Lunec J. p53 overexpression in head and neck carcinoma and radiotherapy results. Int J Radiat Oncol Biol Phys 36 (1996) 323-332
33. Kokoska M.S., Piccirilio J.F., El Mofty S.K., Emami B., Haughey B.H., and Schoinick S.B. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy. Cancer 78 (1996) 1693-1700
34. Motamed M., Banerjee A.R., Bradley P.J., and Powe D. MIB-1 and p53 expression in Radiotherapy-resistant T1aN0M0 glottic squamous cell carcinoma Clin. Otolaryngol 26 (2001) 227-230
35. Fisher C.J., Gillett C.E., Vojtesek B., Barnes D.M., and Millis R.R. Problems with p53 immunohistochemical staining: The effect of fixation and variation in the methods of evaluation. Br J Cancer 69 (1994) 26-31
36. Kwot T.T., and Sutherland R.M. Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low number of EGF receptors. Br J Cancer 64 (1991) 251-254
37. Wen Q.H., Miwa T., Yoshizaki T., Nagayama I., Furukawa M., and Nishijima H. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy. Laryngoscope 106 (1996) 884-888
38. Miyaguchi M., Olofsson J., and Hellquist H.B. Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clin Otolaryngol 16 (1991) 466-469
39. Gupta A.K., McKenna W.G., Weber C.N., Feldman M.D., Goldsmith J.D., Mick R., et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res 8 (2002) 885-892